Indaptus Therapeutics, Inc. (INDP)

USD 0.91

(0.29%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 1284.00 1781.00 1403.00 852.00 854 Thousand 859 Thousand
Gross Profit -1284.00 -1781.00 -1403.00 -852.00 -854 Thousand -859 Thousand
Operating Expenses 16.37 Million 14.91 Million 7.72 Million 3.59 Million 34.09 Million 42.46 Million
Selling, General and Administrative Expenses 8.75 Million 8.58 Million 5.2 Million 944.24 Thousand 7.43 Million 7.06 Million
Research and Development Expenses 7.62 Million 6.32 Million 2.52 Million 2.65 Million 26.65 Million 35.4 Million
Other Expenses - - - - - -
Cost and Expenses 16.37 Million 14.91 Million 7.72 Million 3.59 Million 34.94 Million 43.32 Million
Operating Income -16.37 Million -14.91 Million -7.72 Million -3.59 Million -34.94 Million -43.32 Million
Interest Expense - 588.1 Thousand - - 15 Thousand 23 Thousand
Income Tax Expense - -588.1 Thousand -17.72 Thousand -15.11 Thousand 638 Thousand 103 Thousand
Earnings before Tax -15.42 Million -14.32 Million -7.71 Million -3.58 Million -46.96 Million -43.44 Million
Net Income -15.42 Million -13.73 Million -7.69 Million -3.56 Million -47.59 Million -43.54 Million
Earnings Per Share Basic -1.84 -1.66 -1.88 -7.34 -112.74 -111.67
Earnings Per Share Diluted -1.84 -1.66 -1.88 -7.34 -112.74 -111.67
Weighted Average Shares Outstanding 8.4 Million 8.26 Million 4.09 Million 486.16 Thousand 422.2 Thousand 389.91 Thousand
Weighted Average Shares Outstanding (Diluted) 8.4 Million 8.26 Million 4.09 Million 486.16 Thousand 422.2 Thousand 389.91 Thousand
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -15.42 Million -14.9 Million -7.72 Million -3.59 Million -46.09 Million -42.55 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts